The Society for Immunotherapy of Cancer (SITC) hosted the 2nd World Immunotherapy Council Young Investigator Symposium during the SITC 2017 Annual Meeting on November 8, 2017. Available here are the presentation slides and video for the symposium.Program Organizers
Program SummaryThe Society for Immunotherapy of Cancer (SITC) and the World Immunotherapy Council (WIC) are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.
The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, will contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants will ultimately highlight worldwide initiatives in cancer immunotherapy and facilitate scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum will provide a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives. Intended AudienceThe target audience for this program consists of individuals from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals who wish to learn more about the future of cancer immunotherapy research across the globe.
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session IV: Novel Approaches to Improve Immunotherapy; Presenter: Alessia Covre, PhD – NIBIT Foundation (Network Italiano per la Bioterapia dei Tumori); Date: November 8, 201700:12:43
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session IV: Novel Approaches to Improve Immunotherapy; Presenter: Claudia Lennicke, PhD – Tumor Immunology Meets Oncology (TIMO); Date: November 8, 201700:15:55
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session IV: Novel Approaches to Improve Immunotherapy; Presenter: Takahiro Karasaki, MD – Japanese Association of Cancer Immunology (JACI); Date: November 8, 201700:12:28
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session III: Biomarkers Supporting T Cell Interventions; Presenter: Daniel William Fowler, PhD – Institute for Cancer Vaccines and Immunotherapy (ICVI); Date: November 8, 201700:15:37
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session III: Biomarkers Supporting T Cell Interventions; Presenter: Fang Fang, PhD – Chinese Society of Immunology (CSI) and Committee for Tumor Immunology and Bio-Therapy (TIBT); Date: November 8, 201700:20:18
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session I: Checkpoint Blockade; Presenter: Jan Willem Kleinovink, PhD – Dutch Tumor Immunology Working Party (DTIWP); Date: November 8, 201700:14:26
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session I: Checkpoint Blockade; Presenter: Liang Deng, MD, PhD – Chinese American Hematology Oncology Network (CAHON); Date: November 8, 201700:22:34
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session I: Checkpoint Blockade; Presenter: Alice O. Kamphorst, PhD – Cancer Research Institute (CRI); Date: November 8, 201700:18:13
Meeting: SITC 32 Annual Meeting; Session: 2nd World Immunotherapy Council Young Investigator Symposium; Session I: Checkpoint Blockade; Presenter: Katalin Czirbesz, MD – National Institute of Oncology, Budapest; Date: November 8, 201700:11:12
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us